Amantadine Delayed-Release/Extended-Release Capsules Show More Benefit Compared With Other Formulations - Neurology Live

6/18/2022 12:00:00 AM2 years 10 months ago
by Matt Hoffman
by Matt Hoffman
In a first, but indirect, comparison of the 3 available formulations of amantadine for the treatment of Parkinson disease, only the delayed-release/extended-release formulation (Gocovri) resulted in improvements in both in OFF time and dyskinesia.
Results of an indirect treatment comparison of the 3 available formulations of amantadineimmediate-release tablets, immediate-release/extended-release tablets (Osmolex; Supernus Pharmaceuticals), del… [+3967 chars]
full article...